Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary prourokinase plus vasodilator therapy during emergency PCI for acute myocardial infarction
ChiCTR1900022290Phase 4Not yet recruiting
- Sponsor
- Inner Mongolia Autonomous Region People's Hospital
- Start
- Jan 1990
- Modality
- Small Molecules, Metabolic Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of recombinant human prourokinase, sodium nitroprusside and nitroglycerin in myocardial infarction (MI) (2 arms), sponsored by Inner Mongolia Autonomous Region People's Hospital. Primary endpoint: thrombolysis in myocardial infarction (TIMI). Planned start Jan 1990; status: not yet recruiting.
02
Drugs
recombinant human prourokinasesodium nitroprussidenitroglycerin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR1900022290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022290.